Found: 18
Select item for more details and to access through your institution.
An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 1, p. 1, doi. 10.1002/pul2.12024
- By:
- Publication type:
- Article
Tumor Necrosis Factor-α-Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2002, v. 26, n. 4, p. 465, doi. 10.1165/ajrcmb.26.4.4681
- By:
- Publication type:
- Article
Tumor Necrosis Factor-α-Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 23, n. 6, p. 794, doi. 10.1165/ajrcmb.23.6.4184
- By:
- Publication type:
- Article
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) - a selective CXCR2 antagonist - in healthy adult subjects.
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s40360-015-0017-x
- By:
- Publication type:
- Article
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, n. 1, p. 18, doi. 10.1186/s40360-015-0017-x
- By:
- Publication type:
- Article
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 8, p. 1081, doi. 10.1002/cpdd.693
- By:
- Publication type:
- Article
Pharmacokinetics, Excretion, and Mass Balance of [<sup>14</sup>C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 901, doi. 10.1002/cpdd.616
- By:
- Publication type:
- Article
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma.
- Published in:
- Respiratory Research, 2010, v. 11, p. 26, doi. 10.1186/1465-9921-11-26
- By:
- Publication type:
- Article
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 2, p. 487, doi. 10.1007/s41030-021-00164-7
- By:
- Publication type:
- Article
Predictors of Objective Cough Frequency in Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 187, n. 9, p. 943, doi. 10.1164/rccm.201211-2000OC
- By:
- Publication type:
- Article
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 5, p. 971, doi. 10.1111/bcp.12855
- By:
- Publication type:
- Article
Assessment of potential drug interactions by characterization of human drug metabolism pathways using non-invasive bile sampling.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 2, p. 488, doi. 10.1111/j.1365-2125.2012.04352.x
- By:
- Publication type:
- Article
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 282, doi. 10.1111/j.1365-2125.2011.03968.x
- By:
- Publication type:
- Article
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase.
- Published in:
- ChemBioChem, 2017, v. 18, n. 9, p. 837, doi. 10.1002/cbic.201700014
- By:
- Publication type:
- Article
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660).
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2813, doi. 10.1111/bcp.13398
- By:
- Publication type:
- Article
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4362, doi. 10.3390/jcm11154362
- By:
- Publication type:
- Article